Related Experiment Video
Updated: May 12, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
Published on: March 29, 2024
Oxidative stress in vascular disease and its pharmacological prevention
Huige Li1, Sven Horke, Ulrich Förstermann
1Department of Pharmacology, Johannes Gutenberg University Medical Center, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany.
Abstract:
Cardiovascular risk factors lead to enhanced production of reactive oxygen species (ROS) generated by NADPH oxidase, xanthine oxidase (XO), the mitochondrial electron-transport chain (ETC), and dysfunctional endothelial nitric oxide synthase (eNOS). When the capacity of antioxidant defense systems [e.g., superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), heme oxygenase (HO), paraoxonase (PON)] is exceeded, this results in oxidative stress, which can promote atherogenesis. Therefore, pharmacological means to prevent oxidative stress are of major therapeutic interest. Some established drugs and novel therapeutic approaches can prevent oxidative stress and, presumably, vascular disease. These include angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor type 1 (AT1 receptor) blockers (ARBs), statins, nebivolol, pentaerithrityl tetranitrate (PETN), resveratrol, and mitochondria-targeted antioxidants. Molecular mechanisms involved in the induction of oxidative stress under pathological conditions as well as pharmacological approaches (and their molecular mechanisms) are summarized in this review.
Insights
Cardiovascular risk factors increase reactive oxygen species (ROS), leading to oxidative stress and potential atherogenesis. Pharmacological interventions targeting ROS production and enhancing antioxidant defenses offer therapeutic strategies for vascular disease prevention.
Area of Science:
- Cardiovascular Medicine
- Oxidative Stress Research
- Pharmacology
Background:
- Cardiovascular risk factors elevate reactive oxygen species (ROS) production via enzymes like NADPH oxidase and xanthine oxidase.
- Imbalance between ROS generation and antioxidant defenses (e.g., superoxide dismutase, catalase) causes oxidative stress, a key factor in atherogenesis.
- Dysfunctional endothelial nitric oxide synthase (eNOS) also contributes to oxidative stress in vascular disease.
Purpose of the Study:
- To review the molecular mechanisms underlying oxidative stress induction in pathological conditions.
- To summarize established and novel pharmacological approaches for preventing oxidative stress and vascular disease.
- To highlight the therapeutic potential of targeting ROS production and enhancing antioxidant capacity.
Main Methods:
- Literature review of studies on oxidative stress mechanisms in cardiovascular disease.
- Analysis of established drugs (e.g., ACEIs, ARBs, statins) and novel agents (e.g., resveratrol, mitochondria-targeted antioxidants).
- Examination of molecular targets and pathways involved in ROS generation and antioxidant defense.
Main Results:
- Cardiovascular risk factors significantly enhance ROS production, overwhelming endogenous antioxidant systems.
- Pharmacological agents including ACE inhibitors, ARBs, statins, nebivolol, PETN, resveratrol, and mitochondria-targeted antioxidants demonstrate potential in mitigating oxidative stress.
- These interventions target key enzymes in ROS generation and support antioxidant pathways, offering therapeutic benefits.
Conclusions:
- Oxidative stress is a critical mediator in the development of vascular disease.
- Targeting ROS production and bolstering antioxidant defenses pharmacologically presents a promising therapeutic strategy.
- Further research into these pharmacological interventions may lead to improved prevention and treatment of cardiovascular diseases.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology
Radical Autoxidation

